Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ: ZNTL · Real-Time Price · USD

4.330

-0.120 (-2.70%)

At close: Jul 24, 2026, 4:00 PM EDT

4.340

+0.010 (0.23%)

Pre-market: Jul 27, 2026, 5:44 AM EDT

Zentalis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	31.93	36	33.9	28.04	43.07	59.71
Short-Term Investments	179.83	209.9	337.18	454.88	394.3	280.17
Cash & Short-Term Investments	211.76	245.89	371.08	482.92	437.37	339.89
Cash Growth	-36.30%	-33.74%	-23.16%	10.41%	28.68%	0.41%
Accounts Receivable	-	-	5	-	-	-
Other Current Assets	6.34	7.3	9.98	13.8	14.56	10.88
Total Current Assets	218.1	253.19	386.07	496.72	451.93	350.77
Net Property, Plant & Equipment	28.25	29.04	37.23	41.74	50.08	52.84
Goodwill	-	-	-	3.74	3.74	3.74
Long-Term Investments	-	-	-	-	21.21	37.5
Other Long-Term Assets	6.72	6.74	7.04	9.5	12.35	9.67
Total Assets	253.07	288.97	430.34	551.69	539.31	454.51

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	7.38	7.21	7.44	14.93	11.25	11.59
Accrued Expenses	27.86	29.35	45.29	54.44	45.4	32.35
Total Current Liabilities	35.24	36.56	52.73	69.37	56.65	43.94
Long-Term Leases	34.65	35.7	39.58	43.15	45.17	44.46
Other Long-Term Liabilities	0.5	0.5	0.85	1.78	3.47	1.62
Total Long-Term Liabilities	35.15	36.2	40.43	44.93	48.64	46.08
Total Liabilities	70.39	72.76	93.15	114.3	105.29	90.03

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.07	0.07	0.07	0.07	0.06	0.05
Additional Paid-in Capital	1,409	1,407	1,391	1,324	1,031	723.59
Accumulated Other Comprehensive Income	-0.05	0.2	0.56	2.19	-1.35	-0.13
Retained Earnings	-1,227	-1,191	-1,054	-888.56	-596.37	-359.56
Total Common Shareholders' Equity	182.68	216.2	337.19	437.28	433.8	363.95
Minority Interest	-	-	-	0.11	0.22	0.53
Shareholders' Equity	182.68	216.2	337.19	437.39	434.02	364.48
Total Liabilities & Equity	253.07	288.97	430.34	551.69	539.31	454.51

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	34.65	35.7	39.58	43.15	45.17	44.46
Net Cash (Debt)	177.11	210.19	331.51	439.77	392.21	295.43
Net Cash Growth	-39.72%	-36.60%	-24.62%	12.13%	32.76%	-12.44%
Net Cash Per Share	2.48	2.92	4.66	6.72	7.42	6.92
Book Value	182.68	216.2	337.19	437.28	433.8	363.95
Book Value Per Share	2.55	3.01	4.74	6.69	8.21	8.53
Tangible Book Value	182.68	216.2	337.19	433.55	430.07	360.22
Tangible Book Value Per Share	2.55	3.01	4.74	6.63	8.14	8.44

SEC Filings: 10-K · 10-Q